Generex licenses drug delivery tech for $10M; Evotec acquires Compound Focus in South San Francisco; PPD wins Army contract;

@FierceBiotech: Special Report: 5 emerging eClinical firms to watch. Report | Follow @FierceBiotech

@JohnCFierce: WSJ reports insider trading probe on SAC Capital and the MedImmune acquisition. Article | Follow @JohnCFierce

> Generex has licensed its RapidMist buccal (through the cheek) drug-delivery product to Sunnyvale, CA-based Amarantus BioSciences for $10 million. Story

> Evotec bought up Galapagos NV's South San Francisco-based Compound Focus, a compound management business, for 12.5 million euros. Evotec release

> The CRO PPD has won a $45.5 million, five-year contract to handle clinical trial services for the U.S. Army. PPD release

> AstraZeneca has won Canadian approval for its blockbuster heart drug Brilinta as it continues to jockey for a U.S. OK. Article

> Alexion Pharmaceuticals has won a priority review for Soliris-designed to treat a rare genetic disease--from the FDA. Item

> The US Army Medical Research and Material Command has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a sublingual product for moderate-to-severe acute pain. Release

> Germany's MediGene AG and The Johns Hopkins University agreed to collaborate in the field of AAVLP vaccine technology. Release

Pharma News

@FiercePharma: France to stop paying for Pfizer's Champix. News | Follow @FiercePharma

> Novartis scouts bolt-on deals of up to $3B. Report

> Novo plots China growth to protect market share. Article

> Pfizer, Teva settle long-running Neurontin fight. Story

Drug Delivery News

> MAP Pharma files NDA for orally inhaled migraine treatment. Item

> Fluorescent carbon nanotubes light the way for drug-delivery researchers. Story

> Generex licenses buccal delivery to Amarantus for $10M. Report

> Why we love and hate the blood-brain barrier. Piece

> 'Theragnostic' nanoparticle detects and treats tumors. Article

> Packaging RNA for long-lasting, nontoxic delivery. Item

Medical Device News

> Boston Sci recalls imaging catheters. News

> Shuren to appear before House panel this week. Story

> Neoprobe sells gamma detection biz to Devicor. Item

> Advance Medical raises $6M in Series A. Article

And Finally... After reviewing the literature the World Health Organization reports that cell phones just may trigger brain cancer. Report

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.